into HR action plans supported by Center of Expertise insight and guidance and leading the HR team to drive the agreed actions... and provide the best HR service to the business Provide support and advice for leaders and drive the actions that support the...
. This role sits within the HR Transformation offering, we transform the way HR enables the business and the workforce. People... are at the core of everything we do and there has never been a more exciting time to be a HR professional. We help our clients...
, you will play a crucial role in revolutionizing our HR processes by analyzing business needs, gathering requirements... of our journey and make a lasting impact! What does the role involve Collaborate with our awesome HR and IT teams to understand...
Management/ Training records in the HR system. Manage and process training administration including training registrations..., payments and HRDC administration. Responsible for talent/ training data governance and ensure continual updates to HR system...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »